anorexia nervosa: A disorder most often seen in adolescent females characterized by a refusal to maintain a minimally normal body weight, an intense fear of gaining weight, a disturbance in body image, and, in postmenarcheal females, the development of amenorrhea.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2717 |
4. Check minimum number of eventsNone |
2717 |
5. Include endpointsNone |
2717 |
6. Filter based on genotype QC (FinnGen only) |
2717 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHAVE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Anorexia (incl.atypical)
based on the number of shared cases.
Similar with more cases:
- Eating disorders
- Behavioural syndromes associated with physiological disturbances and physical factors
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 30794 | 23074 | 7457 |
| Only index persons | 25075 | 20032 | 5043 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.55 | 0.66 | 0.21 |
| Only index persons | 0.63 | 0.74 | 0.19 |
| Median age at first event (years) | |||
| Whole population | 20.13 | 17.91 | 25.85 |
| Only index persons | 17.62 | 17.10 | 19.70 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2717 | 2183 | 534 |
| Unadjusted period prevalence (%) | 0.64 | 0.74 | 0.24 |
| Median age at first event (years) | 19.20 | 18.31 | 22.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2442
- Matched controls
- 24428
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F50.1
ICD-10 Finland
Atypical anorexia nervosa
1690.3
323.0
799
7
78410
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Emesis
+∞
323.0
371
*
F50.9
ICD-10 Finland
Eating disorder, unspecified
260.6
323.0
665
35
F50.0
ICD-10 Finland
Anorexia nervosa
3312.5
323.0
1083
6
F50.2
ICD-10 Finland
Bulimia nervosa
204.5
233.9
240
13
N06AB03
ATC
fluoxetine; oral
6.0
214.0
677
1460
P86
ICPC
Anorexia nervosa/bulimia
71.3
177.4
203
31
78419
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Nausea NUD
+∞
175.1
166
*
N05AH04
ATC
quetiapine; oral
4.2
169.5
799
2550
78450
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Haematemesis
+∞
167.7
159
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.3
159.4
718
2177
N91.1
ICD-10 Finland
Secondary amenorrhoea
9.3
142.8
313
378
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.5
138.7
457
984
F50.8
ICD-10 Finland
Other eating disorders
245.5
136.5
139
6
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
132.5
126
*
F50.3
ICD-10 Finland
Atypical bulimia nervosa
97.5
125.5
138
15
N05AH03
ATC
olanzapine; systemic
5.7
108.9
338
666
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.0
107.5
492
1450
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
105.2
566
1908
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.0
99.9
352
798
78400
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Anorexia
+∞
96.5
92
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.8
95.7
290
551
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
89.5
268
500
N06AX16
ATC
venlafaxine; oral
3.3
88.6
534
1934
IBZ05
NOMESCO Finland
Evaluation of patient with eating disorder
+∞
84.9
81
*
ZY010
NOMESCO Finland
Hospital outpatient
4.5
81.2
313
771
N05BA04
ATC
oxazepam; oral
2.6
80.4
731
3421
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.9
77.9
232
428
N06AX11
ATC
mirtazapine; oral
2.5
77.0
827
4218
N06AB06
ATC
sertraline; oral
3.2
76.6
455
1614
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
76.5
670
3050
R63.0
ICD-10 Finland
Anorexia
47.2
74.5
91
20
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.2
72.4
297
773
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
72.0
498
1953
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.6
71.1
219
420
N05AX12
ATC
aripiprazole; systemic
4.9
69.7
246
550
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.8
68.4
242
542
N05AX08
ATC
risperidone; systemic
4.1
68.1
287
764
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.7
67.9
246
565
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.1
65.9
169
254
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.6
65.5
201
383
78440
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Dysphagia
+∞
64.9
62
*
N03AX09
ATC
lamotrigine; oral
4.2
64.8
265
685
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.3
61.5
199
403
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.9
60.6
144
193
Z3226
NOMESCO Finland
Physiotherapist
2.6
59.0
496
2162
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.2
58.2
164
280
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.2
57.9
146
214
N06AB10
ATC
escitalopram; oral
2.2
57.2
702
3715
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
57.1
292
912
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.0
56.3
241
647
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.7
53.8
192
432
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.1
53.7
153
265
IER01
NOMESCO Finland
Psychoeducation, group
16.0
53.5
88
57
Z2446
NOMESCO Finland
Social worker
3.6
53.4
264
801
T08
ICPC
Weight loss
9.2
53.2
114
129
N06AB04
ATC
citalopram; systemic
2.3
52.0
554
2718
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.6
51.8
427
1829
R63.4
ICD-10 Finland
Abnormal weight loss
6.4
51.0
140
231
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
6.9
48.5
125
189
Z3231
NOMESCO Finland
Registered nurse
2.1
48.4
670
3689
Z2445
NOMESCO Finland
Psychologist
3.7
47.0
219
631
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
46.7
183
451
E87.6
ICD-10 Finland
Hypokalaemia
7.8
46.6
110
146
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.7
44.3
132
242
G03DB01
ATC
dydrogesterone; oral
2.4
42.0
419
1967
N05AA02
ATC
levomepromazine; systemic
4.9
41.6
142
304
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.7
40.7
97
131
ZY000
NOMESCO Finland
Hospital inpatient
7.5
39.8
96
132
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.6
39.2
188
553
N05CF01
ATC
zopiclone; oral
2.0
38.1
602
3445
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.1
37.6
123
251
7830A
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Anorexia
+∞
37.6
36
*
N03AG01
ATC
valproic acid; systemic, rectal
3.4
37.4
195
613
N05BA06
ATC
lorazepam; systemic, sublingual
4.3
37.2
143
346
N05AF03
ATC
chlorprothixene; systemic
5.9
36.9
106
186
N05BA01
ATC
diazepam; systemic, rectal
2.5
36.5
305
1297
R4190
NOMESCO Finland
Nutritional therapy
4.3
36.3
140
339
F61.0
ICD-10 Finland
Mixed personality disorders
6.3
36.2
99
163
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
36.2
182
556
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.9
35.9
242
906
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
35.3
192
622
N06AX12
ATC
bupropion; oral
2.8
35.2
242
917
F93.89
ICD-10 Finland
Other childhood emotional disorders
5.7
35.0
104
190
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
7.0
34.8
88
130
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
34.7
195
645
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.5
33.5
74
89
AA400
NOMESCO Finland
Electroconvulsive therapy
10.9
33.2
64
60
F50
ICD-10 Finland
Eating disorders
33.6
33.2
43
13
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.4
33.1
125
297
P29
ICPC
Psychological sympt/compl other
2.6
31.7
258
1076
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
3.7
31.3
143
404
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.3
31.1
118
282
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.6
30.8
110
247
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
17.5
30.6
48
28
N06AB05
ATC
paroxetine; oral
3.1
30.4
180
618
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
8.0
30.4
70
90
N06AX21
ATC
duloxetine; oral
2.4
30.3
270
1185
N05AH02
ATC
clozapine; systemic
5.2
30.3
96
190
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
30.1
169
558
ZYC01
NOMESCO Finland
Remote contact by phone
3.3
30.0
161
516
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.1
30.0
170
567
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
29.8
519
3041
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
8.3
29.6
66
81
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
8.8
29.2
63
73
P01
ICPC
Feeling anxious/nervous/tense
1.9
29.2
514
3023
N05BE01
ATC
buspirone; oral
5.0
29.1
96
199
C07AA05
ATC
propranolol; systemic
1.9
29.0
508
2980
F32.1
ICD-10 Finland
Moderate depressive episode
2.6
28.8
231
955
F34.1
ICD-10 Finland
Dysthymia
3.5
28.7
140
417
P11
ICPC
Eating problem in child
27.5
28.0
38
14
RF220
NOMESCO Finland
NA
7.1
27.8
69
100
T05
ICPC
Feeding problem of adult
7.1
27.8
69
100
F50.5
ICD-10 Finland
Vomiting associated with other psychological disturbances
146.7
27.7
29
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.5
27.7
100
228
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
27.4
924
6608
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.5
27.2
133
397
R53
ICD-10 Finland
Malaise and fatigue
1.8
27.0
513
3085
RT230
NOMESCO Finland
NA
46.3
26.5
32
7
N03AX16
ATC
pregabalin; oral
1.9
26.4
426
2417
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.9
26.0
110
291
N06AX03
ATC
mianserin; oral
3.9
26.0
111
296
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.4
25.6
94
218
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.8
25.5
111
302
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
8.2
25.4
57
71
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.6
25.2
116
330
RD210
NOMESCO Finland
NA
4.7
24.7
86
189
N05AN01
ATC
lithium; oral
4.4
24.4
91
215
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
34.9
24.3
31
9
Z2221
NOMESCO Finland
Medical doctor
1.7
24.2
654
4367
N91.0
ICD-10 Finland
Primary amenorrhoea
13.9
24.0
41
30
N05CD07
ATC
temazepam; oral
2.6
23.6
185
757
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.6
23.5
108
308
N03AE01
ATC
clonazepam; systemic
3.2
23.4
129
422
P76
ICPC
Depressive disorder
2.3
23.3
235
1092
SPAT1240
SPAT
Therapeutic discussion
1.9
23.1
408
2382
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.5
23.1
110
323
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
4.6
22.9
80
177
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
22.7
206
910
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.7
22.2
155
591
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.0
22.2
129
439
A04
ICPC
Weakness/tiredness general
1.9
22.1
388
2255
F60.5
ICD-10 Finland
Anankastic personality disorder
5.7
21.9
63
112
R11
ICD-10 Finland
Nausea and vomiting
2.2
21.9
233
1111
R4140
NOMESCO Finland
Psychotherapy
7.0
21.7
54
79
F51.0
ICD-10 Finland
Nonorganic insomnia
1.9
21.5
322
1767
K59.0
ICD-10 Finland
Constipation
2.9
21.1
131
464
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.6
21.0
97
278
N06AX26
ATC
vortioxetine; oral
2.4
20.7
185
811
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.7
20.7
143
544
F32.8
ICD-10 Finland
Other depressive episodes
4.3
20.5
76
179
ZXY60
NOMESCO Finland
2-person team, nurses
7.3
20.5
49
68
SPAT1307
SPAT
Psychosocial counselling and guidance
1.9
20.3
317
1765
A03FA02
ATC
cisapride; oral, rectal
2.6
20.3
152
606
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
3.1
20.3
115
383
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.9
20.1
339
1940
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.9
19.8
65
135
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.7
19.4
66
143
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.7
19.4
49
74
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.5
19.0
68
155
N07BB01
ATC
disulfiram; oral
3.3
18.9
98
308
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.2
18.8
71
171
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
8.6
18.6
40
47
30650
ICD-8 Finland
Special symptoms not elsewhere classified, Feeding disturbance
100.8
18.6
20
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
18.4
412
2578
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.8
18.3
124
464
N05CF02
ATC
zolpidem; oral
1.8
18.3
337
1981
N05AB03
ATC
perphenazine; systemic, rectal
3.2
18.2
98
317
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.7
18.1
79
217
K59.09
ICD-10 Finland
Constipation, unspecified
2.8
18.1
119
439
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.5
17.9
86
255
N06AX05
ATC
trazodone; oral
3.8
17.9
77
209
A06AD11
ATC
lactulose; oral
2.1
17.9
226
1157
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
9.6
17.9
36
38
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
4.3
17.8
66
156
R5599
NOMESCO Finland
Other rehabilitation service
3.6
17.8
81
230
N03AX12
ATC
gabapentin; oral
1.9
17.8
267
1463
RS214
NOMESCO Finland
NA
15.7
17.5
28
18
SPAT1139
SPAT
Nutrition survey
3.1
17.5
97
321
RS210
NOMESCO Finland
NA
13.2
17.4
30
23
F33
ICD-10 Finland
Recurrent depressive disorder
3.4
17.2
83
248
AA1AD
NOMESCO Finland
CT of head and brain
1.8
17.2
336
2016
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.9
17.1
71
187
F40.1
ICD-10 Finland
Social phobias
2.8
17.0
113
419
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.7
17.0
121
468
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.8
16.9
110
404
X78
ICD-10 Finland
Intentional self-harm by sharp object
5.6
16.9
49
89
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.8
16.8
72
195
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.6
16.8
77
221
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.2
16.7
51
99
Z71.8
ICD-10 Finland
Other specified counselling
1.5
16.6
616
4388
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.7
16.6
74
207
R55
ICD-10 Finland
Syncope and collapse
2.1
16.5
201
1012
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.3
16.4
61
145
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
16.3
168
787
P74
ICPC
Anxiety disorder/anxiety state
2.2
16.3
166
775
ZXY49
NOMESCO Finland
Other health care provider
7.2
16.3
39
55
N04AA02
ATC
biperiden; systemic
4.5
16.2
57
129
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
16.1
138
592
A02BC01
ATC
omeprazole; systemic
1.6
16.1
502
3425
N03AF01
ATC
carbamazepine; oral, rectal
2.9
16.0
99
353
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
15.9
410
2660
H03AA01
ATC
levothyroxine sodium; systemic
1.6
15.8
453
3022
IEY01
NOMESCO Finland
Psychoeducation, individual
5.1
15.8
49
97
P03
ICPC
Feeling depressed
1.7
15.7
341
2106
A10AA02
ATC
NA
3.0
15.6
92
318
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
7.9
15.6
35
45
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.1
15.6
85
279
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.8
15.5
103
381
N05AD01
ATC
haloperidol; systemic
3.6
15.5
71
204
P99
ICPC
Psychological disorders other
3.0
15.3
91
316
30041
ICD-8 Finland
Neuroses, Depressiva
9.8
15.2
30
31
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
15.1
430
2863
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.5
15.1
117
477
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
15.1
393
2557
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.4
15.0
73
220
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
15.0
266
1543
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
14.8
308
1877
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
57.0
14.8
17
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
14.7
224
1231
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.4
14.7
70
208
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
6.9
14.7
36
53
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.8
14.7
62
167
N05BA12
ATC
alprazolam; oral
2.0
14.6
188
971
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
8.1
14.5
32
40
IGV01
NOMESCO Finland
Psychiatric network contact
4.9
14.5
47
98
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.0
14.5
57
144
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.6
14.5
64
179
N06AG02
ATC
moclobemide; oral
2.9
14.4
86
300
F32
ICD-10 Finland
Depressive episode
2.1
14.2
167
828
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
6.8
14.2
35
52
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
4.8
14.1
46
97
79199
ICD-8 Finland
Headache
7.3
14.0
33
46
F45.8
ICD-10 Finland
Other somatoform disorders
1.8
14.0
231
1308
F84.5
ICD-10 Finland
Asperger syndrome
5.9
13.9
38
65
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.3
13.9
69
212
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
13.9
139
643
A02BC03
ATC
lansoprazole; oral
1.6
13.7
444
3046
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.6
13.7
47
104
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
13.7
176
906
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.0
13.6
54
138
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
13.6
505
3577
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
8.8
13.5
28
32
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
5.9
13.4
37
64
N06AB08
ATC
fluvoxamine; oral
3.6
13.4
60
170
A10AA01
ATC
NA
2.9
13.4
79
274
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.7
13.4
58
160
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.3
13.4
68
213
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
18.3
13.4
20
11
N06AA12
ATC
doxepin; systemic
2.8
13.3
83
298
IGP01
NOMESCO Finland
Psychiatric family contact
4.5
13.3
46
103
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
4.8
13.3
43
90
F60.0
ICD-10 Finland
Paranoid personality disorder
10.5
13.2
25
24
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
5.1
13.0
40
79
R51.80
ICD-10 Finland
Headache
1.6
13.0
395
2666
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
13.0
93
363
RT310
NOMESCO Finland
NA
28.5
13.0
17
6
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
12.9
169
879
53502
ICD-8 Finland
Gastritis and duodenitis, Gastritis acuta NUD
13.0
12.9
22
17
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
12.8
256
1540
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
12.8
263
1595
N06AA06
ATC
trimipramine; systemic
4.1
12.8
49
122
X84
ICD-10 Finland
Intentional self-harm by unspecified means
8.5
12.7
27
32
Y0599
ICD-8 Finland
Investigation of digestive system
4.5
12.6
44
100
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.1
12.6
39
78
N05AA01
ATC
chlorpromazine; systemic, rectal
5.7
12.5
35
62
SPAT1389
SPAT
Visit based on need for special support
2.1
12.4
148
743
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
12.4
367
2461
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
7.6
12.4
28
37
D01
ICPC
Abdominal pain/cramps general
1.6
12.2
322
2093
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
12.1
134
650
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
7.8
12.1
27
35
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.7
12.1
83
315
N05AL01
ATC
sulpiride; systemic
5.3
12.1
36
69
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.0
12.1
147
740
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
5.9
12.1
33
57
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
5.1
12.0
37
74
N06AX22
ATC
agomelatine; oral
2.9
11.9
70
243
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
11.8
145
734
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.4
11.6
34
64
F33.8
ICD-10 Finland
Other recurrent depressive disorders
4.5
11.6
40
90
F61
ICD-10 Finland
Mixed and other personality disorders
7.7
11.6
26
34
P15
ICPC
Chronic alcohol abuse
3.3
11.6
56
170
SPAT1284
SPAT
Extensive health certificate
2.6
11.6
87
348
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
11.6
146
750
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.2
11.6
113
518
E86
ICD-10 Finland
Volume depletion
3.8
11.4
47
125
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
120.6
11.4
12
*
T06
ICPC
ANOREXIA NERVOSA W/WO BULIMIA
120.6
11.4
12
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
11.4
660
5087
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
11.4
215
1270
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
11.9
11.3
20
17
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.2
11.3
117
553
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
11.3
287
1847
IBZ99
NOMESCO Finland
Other behavioural observation
35.2
11.3
14
*
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
9.6
11.2
22
23
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
7.3
11.2
26
36
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.3
11.2
26
36
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.1
11.2
132
659
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.7
11.2
47
128
RT250
NOMESCO Finland
NA
12.8
11.1
19
15
A02BC02
ATC
pantoprazole; systemic
1.3
11.1
1126
9511
R42
ICD-10 Finland
Dizziness and giddiness
1.5
11.1
354
2412
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.6
11.1
48
134
M79.6
ICD-10 Finland
Pain in limb
1.4
11.0
657
5083
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
11.2
11.0
20
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
11.0
345
2340
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
8.6
11.0
23
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
10.9
623
4781
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.3
10.9
102
460
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
10.9
153
819
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
12.0
10.8
19
16
SPAT1234
SPAT
Support of social functional capacity
2.4
10.8
87
366
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
10.8
72
272
A02BC05
ATC
esomeprazole; systemic
1.4
10.7
655
5083
K03.2
ICD-10 Finland
Erosion of teeth
2.9
10.6
63
221
I73.0
ICD-10 Finland
Raynaud syndrome
3.5
10.6
49
144
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
10.6
140
730
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
10.6
128
647
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
7.0
10.6
25
36
IEP99
NOMESCO Finland
Other psychiatric family intervention
5.2
10.4
31
60
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
10.4
113
546
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
5.6
10.4
29
52
G44.2
ICD-10 Finland
Tension-type headache
1.6
10.4
310
2076
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.1
10.3
110
527
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.4
10.3
83
347
N05BA02
ATC
chlordiazepoxide; systemic
3.8
10.3
42
112
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
9.6
10.2
20
21
RF210
NOMESCO Finland
NA
2.7
10.2
68
254
N06AA04
ATC
clomipramine; systemic
3.8
10.2
41
108
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.4
10.2
85
363
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
10.1
287
1901
R4110
NOMESCO Finland
Physiotherapy
1.5
10.1
432
3132
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.0
10.0
57
193
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.7
10.0
42
115
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
10.0
337
2322
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.2
10.0
36
86
C07AB02
ATC
metoprolol; systemic
1.6
9.9
246
1573
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
4.8
9.9
32
68
D12
ICPC
Constipation
2.7
9.9
64
238
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
9.9
120
606
F31
ICD-10 Finland
Bipolar affective disorder
3.7
9.9
41
111
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
9.6
9.8
19
20
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
9.7
151
836
F41.00
ICD-10 Finland
Moderate panic disorder
2.8
9.7
62
229
F21
ICD-10 Finland
Schizotypal disorder
5.3
9.7
28
53
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
9.7
145
796
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.7
9.6
31
66
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
6.4
9.5
24
38
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.5
9.5
43
125
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
5.2
9.5
28
54
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.7
9.5
61
226
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.0
9.5
25
42
H3603, E103
ICD-10 Finland
NA
3.9
9.5
37
95
UJF32
NOMESCO Finland
Coloscopy
1.5
9.5
351
2469
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
9.5
206
1268
RT110
NOMESCO Finland
NA
100.4
9.4
10
*
78430
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Heartburn
+∞
9.4
9
*
N06AX18
ATC
reboxetine; oral
5.3
9.4
27
51
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.4
9.3
43
128
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
9.5
9.3
18
19
M81.8
ICD-10 Finland
Other osteoporosis
6.4
9.2
23
36
188
Kela drug reimbursment
Psychosis requiring demanding treatment
4.4
9.2
32
74
S51.7
ICD-10 Finland
Multiple open wounds of forearm
7.3
9.2
21
29
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
9.2
256
1686
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.3
9.1
44
135
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.4
9.1
75
317
K04
ICPC
Palpitations/awareness of heart
2.1
9.1
103
507
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
4.6
9.1
30
66
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
9.1
191
1168
E0000UV
ATC
NA
1.3
9.0
867
7194
IDR02
NOMESCO Finland
Systematic group therapy, cognitive
36.8
9.0
11
*
F60.8
ICD-10 Finland
Other specific personality disorders
4.3
9.0
32
76
Z72.8
ICD-10 Finland
Other problems related to lifestyle
4.9
9.0
28
58
R33
ICD-10 Finland
Retention of urine
2.2
9.0
88
408
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.5
8.9
40
116
T89
ICPC
Diabetes insulin dependent
2.1
8.8
92
437
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
10.7
8.8
16
15
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
6.3
8.8
22
35
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
8.8
576
4506
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.2
8.7
86
397
RS220
NOMESCO Finland
NA
3.7
8.7
36
98
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.7
923
7755
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
14.1
8.7
14
10
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
8.7
228
1477
X05
ICPC
Menstruation absent/scanty
2.5
8.7
66
269
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.5
8.7
39
114
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
6.2
8.6
22
36
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.2
8.6
31
75
N06BA04
ATC
methylphenidate; oral
2.2
8.5
80
363
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
9.0
8.5
17
19
RF430
NOMESCO Finland
NA
7.4
8.4
19
26
SPAT1310
SPAT
Counselling related to known health issue
1.3
8.4
724
5898
F50.4
ICD-10 Finland
Overeating associated with other psychological disturbances
90.4
8.4
9
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
8.4
50
178
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.4
332
2366
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
4.2
8.4
30
72
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
4.5
8.3
28
63
ZXY03
NOMESCO Finland
Occupational therapist
6.2
8.3
21
34
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
10.8
8.3
15
14
A02BA02
ATC
ranitidine; systemic
1.5
8.3
255
1719
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.1
8.3
90
435
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
7.1
8.2
19
27
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
8.2
156
926
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
8.2
250
1682
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
4.9
8.2
25
51
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.5
8.2
27
60
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
4.3
8.1
28
65
A10AE04
ATC
insulin glargine; parenteral
1.8
8.1
141
817
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
22.1
8.0
11
5
N03AF02
ATC
oxcarbazepine; oral
2.4
8.0
65
275
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
6.3
8.0
20
32
S29
ICPC
Skin symptom/complaint other
1.5
8.0
315
2242
ZYD01
NOMESCO Finland
Emergency clinic
5.5
8.0
22
40
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
7.9
592
4715
P72
ICPC
Schizophrenia
3.0
7.9
43
145
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
7.9
281
1958
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
13.1
7.9
13
10
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.8
7.8
31
82
R52.9
ICD-10 Finland
Pain, unspecified
1.7
7.8
145
855
RD112
NOMESCO Finland
NA
9.4
7.8
15
16
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
9.4
7.8
15
16
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.3
7.8
69
305
R13
ICD-10 Finland
Dysphagia
2.0
7.8
89
443
N05AF01
ATC
flupentixol; systemic
3.6
7.7
33
93
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.7
759
6285
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
45.1
7.7
9
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.7
1073
9301
F28
ICD-10 Finland
Other nonorganic psychotic disorders
5.6
7.7
21
38
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.7
339
2469
P06
ICPC
Sleep disturbance
1.6
7.6
208
1362
N05CD02
ATC
nitrazepam; oral
4.4
7.6
26
60
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
7.6
97
504
D06
ICPC
Abdominal pain localized other
1.6
7.6
203
1321
30010
ICD-8 Finland
Neuroses, Hysterical neurosis
18.4
7.6
11
6
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
8.0
7.6
16
20
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.9
7.6
44
154
H04AA01
ATC
glucagon; nasal, parenteral
2.2
7.6
74
345
R52.2
ICD-10 Finland
Other chronic pain
2.4
7.6
62
263
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.0
7.6
28
70
R06.0
ICD-10 Finland
Dyspnoea
1.4
7.5
383
2858
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
10.0
7.5
14
14
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
7.5
446
3423
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
5.8
7.5
20
35
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
5.8
7.5
20
35
C03CA01
ATC
furosemide; systemic
1.5
7.5
281
1978
R02
ICPC
Shortness of breath/dyspnoea
1.6
7.5
209
1379
L17
ICPC
Foot/toe symptom/complaint
1.4
7.4
467
3613
A10AE05
ATC
insulin detemir; parenteral
1.9
7.4
101
537
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
4.1
7.4
27
67
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.3
161
995
N03AX11
ATC
topiramate; oral
2.3
7.3
64
284
3075B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]
+∞
7.3
7
*
F55
ICD-10 Finland
Abuse of non-dependence-producing substances
+∞
7.3
7
*
ZXE00
NOMESCO Finland
One hour or less
1.3
7.3
799
6704
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
3.2
7.3
35
109
R63.1
ICD-10 Finland
Polydipsia
9.4
7.3
14
15
-
ICD-10 Finland
NA
2.7
7.3
45
166
SPAT1260
SPAT
Consultation of another employee
1.4
7.3
347
2563
R03BB01
ATC
ipratropium bromide; inhalant
2.5
7.2
52
209
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
5.2
7.2
21
41
62600
ICD-8 Finland
Disorders of menstruation, Absent
15.8
7.2
11
7
RS140
NOMESCO Finland
NA
5.8
7.2
19
33
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
7.2
138
821
P80
ICPC
Personality disorder
4.3
7.2
25
59
X58
ICD-10 Finland
Exposure to other specified factors
1.5
7.2
261
1823
53508
ICD-8 Finland
Gastritis and duodenitis, Gastroduodenitis NUD
30.1
7.1
9
*
IDP01
NOMESCO Finland
Systematic family therapy, family therapy
20.1
7.1
10
5
S76
ICPC
Skin infection other
2.0
7.1
84
422
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.5
7.1
51
205
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.0
7.1
38
128
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
5.0
7.1
21
42
N91.2
ICD-10 Finland
Amenorrhoea, unspecified
3.2
7.1
34
106
H3600, E103
ICD-10 Finland
NA
3.1
7.1
36
117
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.0
7.1
86
438
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.5
7.1
23
51
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
5.6
7.1
19
34
1310
FHL
Esophagogastroscopy
8.8
7.0
14
16
RS123
NOMESCO Finland
NA
10.0
7.0
13
13
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
3.4
7.0
31
91
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
7.0
306
2224
602
Kela drug reimbursment
Children's severe malnutrition
4.9
7.0
21
43
Z01.7
ICD-10 Finland
Laboratory examination
1.5
7.0
202
1343
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.6
6.9
117
1855
A28
ICPC
Limited function/disability NOS
1.7
6.9
149
921
R4120
NOMESCO Finland
Occupational therapy
1.9
6.9
103
567
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
5.8
6.9
18
31
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
6.9
684
5654
IDY24
NOMESCO Finland
Systematic individual treatment, dialectical behaviour therapy (DBT), pre-treatment
13.8
6.9
11
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
6.9
107
599
V03AA01
ATC
NA
3.9
6.9
26
67
D11
ICPC
Diarrhoea
1.4
6.9
283
2033
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.8
6.8
21
44
V03AG01
ATC
sodium cellulose phosphate; systemic
8.3
6.8
14
17
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.1
6.8
35
115
N02AA05
ATC
oxycodone; systemic
1.6
6.8
156
981
N05AE04
ATC
ziprasidone; systemic
3.5
6.8
29
83
P23
ICPC
Adolescent behaviour sympt/compl
3.5
6.8
29
83
K30
ICD-10 Finland
Functional dyspepsia
1.6
6.8
182
1189
F10.24
ICD-10 Finland
Alcohol depence active use
3.7
6.8
27
73
S18
ICPC
Laceration/cut
1.3
6.7
664
5484
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.7
172
1112
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
6.7
138
842
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.6
303
2218
L01
ICPC
Neck symptom/complaint
1.4
6.6
284
2053
F20.10
ICD-10 Finland
Raise schizophrenia continuously
6.4
6.6
16
25
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
3.1
6.6
34
112
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.5
6.6
48
195
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.4
6.6
29
85
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
8.7
6.5
13
15
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
6.5
681
5662
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
10.0
6.5
12
12
K62.3
ICD-10 Finland
Rectal prolapse
4.3
6.5
22
51
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
6.5
151
952
R00.2
ICD-10 Finland
Palpitations
1.6
6.4
141
876
A01
ICPC
Pain general/multiple sites
1.7
6.4
136
837
F32.0
ICD-10 Finland
Mild depressive episode
2.1
6.4
66
318
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.9
6.4
37
131
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.8
6.4
38
138
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
4.4
6.3
21
48
N06AA09
ATC
amitriptyline; systemic
1.7
6.3
120
716
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
6.6
6.3
15
23
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
8.2
6.3
13
16
M79.1
ICD-10 Finland
Myalgia
1.5
6.3
250
1778
N05AE03
ATC
sertindole; oral
5.5
6.3
17
31
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
9.3
6.3
12
13
RT420
NOMESCO Finland
NA
9.3
6.3
12
13
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.6
6.3
26
73
Z72.2
ICD-10 Finland
Drug use
3.7
6.3
25
68
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
18.1
6.3
9
5
30088
ICD-8 Finland
Neuroses, Other
18.1
6.3
9
5
RF120
NOMESCO Finland
NA
3.3
6.3
29
89
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
6.3
304
2249
RT236
NOMESCO Finland
NA
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.2
271
1966
79020
ICD-8 Finland
Nervousness and debility, Depression
26.7
6.2
8
*
5353A
ICD-9 Finland
Gastritis and duodenitis, Alcoholic gastritis
26.7
6.2
8
*
P98
ICPC
Psychosis NOS/other
4.3
6.2
21
49
IGY02
SPAT
NA
3.8
6.2
24
64
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
6.2
174
1154
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.1
48
203
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
5.7
6.1
16
28
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
6.1
100
567
P27
ICPC
Fear of mental disorder
2.8
6.1
36
129
1320
FHL
Esophagoscopy
7.7
6.1
13
17
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.4
6.1
27
80
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
3.4
6.1
27
80
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
4.2
6.1
21
50
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
2.5
6.1
44
178
H13
ICPC
Plugged feeling ear
1.5
6.1
235
1666
78570
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Melaena (not of newborn)
12.5
6.1
10
8
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.1
299
2220
R07.3
ICD-10 Finland
Other chest pain
1.6
6.1
134
835
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
10.0
6.0
11
11
30188
ICD-8 Finland
Personality disorders, Alia definita
10.0
6.0
11
11
A02BX02
ATC
sucralfate; oral
2.3
6.0
52
229
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.0
454
3607
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
627
1913
3.96
178.33
7.1
5.7
mmol/l
1.1
1.1
10.88
585
1800
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
499
1391
4.17
159.78
3.6
2.4
g/l
0.2
0.2
0.48
456
1305
(3015377) Calcium [Moles/volume] in Serum or Plasma
1058
5585
2.46
105.94
3.1
2.8
mmol/l
2.4
2.3
1.21
962
4987
(3012095) Magnesium [Moles/volume] in Serum or Plasma
569
2437
2.69
86.00
3.9
3.5
mmol/l
0.8
0.8
1.05
532
2276
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1316
8272
2.14
80.73
2.9
2.2
nmol/l
75.0
72.4
2.82
1230
7658
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1281
8023
2.13
78.72
7.7
5.8
mmol/l
1.2
1.2
1.22
1104
6734
(3019309) Folate [Moles/volume] in Red Blood Cells
577
2620
2.53
76.49
1.9
1.7
nmol/l
1271.1
1171.0
1.70
465
2004
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1109
6633
2.13
76.26
2.1
1.7
pmol/l
97.6
97.4
0.06
603
3626
(3024561) Albumin [Mass/volume] in Serum or Plasma
1151
7020
2.11
74.80
5.1
4.4
g/l
37.6
36.5
7.98
1051
6521
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1153
7169
2.06
69.83
6.6
5.2
mmol/l
1.2
1.2
1.98
1066
6511
(3018418) pH of Serum or Plasma
825
4623
2.13
65.16
4.5
3.4
ph
7.4
7.4
0.92
152
910
(3028707) Methadone [Presence] in Urine by Screen method
248
780
3.40
64.09
2.6
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1864
14309
1.96
55.90
7.4
6.2
u/l
70.0
73.4
3.42
1757
13413
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
876
5266
1.98
55.36
2.7
2.1
mg/l
2.6
2.7
0.66
752
4511
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
996
6363
1.89
51.68
1.6
1.3
u/ml
1.0
1.6
2.29
272
1738
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
579
3092
2.11
50.09
2.1
1.6
%
1.5
1.4
5.95
521
2806
(3021960) Folate [Moles/volume] in Serum or Plasma
660
3700
2.03
50.05
1.7
1.4
nmol/l
21.8
20.5
1.58
598
3242
(3036481) Cortisol [Moles/volume] in Serum or Plasma
420
1989
2.31
48.90
1.9
2.0
nmol/l
424.7
382.9
3.63
379
1818
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
905
5776
1.85
45.89
3.4
2.3
u/l
60.1
55.8
2.73
827
5341
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
511
2698
2.10
45.09
2.5
2.5
mmol/l
2.4
2.4
1.72
447
2330
(42870588) Differential panel, method unspecified - Blood
1000
6641
1.80
44.09
6.5
5.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
308
1339
2.47
43.22
3.1
2.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
204
723
2.97
42.78
1.8
1.5
nmol/l
0.3
0.5
3.97
160
610
(3001604) Monocytes [#/volume] in Blood
1410
10433
1.73
41.84
7.3
5.5
e9/l
0.5
0.5
7.22
1241
9202
(3006315) Basophils [#/volume] in Blood
1412
10465
1.73
41.54
7.3
5.5
e9/l
0.0
0.0
2.23
1245
9226
(3009214) Lutropin [Units/volume] in Serum or Plasma
281
1198
2.50
41.05
1.7
1.4
u/l
6.2
9.0
5.92
219
982
(3013650) Neutrophils [#/volume] in Blood by Automated count
1566
11971
1.73
40.90
11.0
7.7
e9/l
3.7
4.0
8.34
1390
10515
(3019198) Lymphocytes [#/volume] in Blood
1454
10903
1.72
40.63
7.2
5.5
e9/l
1.9
2.0
3.34
1296
9821
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
980
6611
1.75
40.00
3.4
3.0
u/l
29.0
29.1
0.02
930
6295
(3013115) Eosinophils [#/volume] in Blood
1445
10856
1.71
39.75
7.7
5.7
e9/l
0.2
0.2
6.02
1288
9728
(3007164) IgA [Mass/volume] in Serum or Plasma
829
5369
1.78
38.71
1.5
1.4
g/l
1.9
2.1
2.88
478
3381
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1581
12238
1.70
38.28
3.7
2.8
ug/l
68.9
70.1
0.07
1494
11516
(3013826) Glucose [Moles/volume] in Serum or Plasma
1461
11128
1.68
37.12
5.3
4.1
mmol/l
6.2
6.3
0.83
1337
9877
(3044889) 12 lead EKG panel
1556
12055
1.68
36.97
4.1
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2114
17843
1.83
36.54
5.5
4.0
pmol/l
14.0
14.4
13.12
1978
16434
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
719
4563
1.78
35.45
2.5
2.0
u/l
277.5
196.0
0.26
681
4315
(3021387) Prolactin [Units/volume] in Serum or Plasma
364
1872
2.09
33.75
1.8
1.6
mu/l
342.2
309.2
0.72
318
1674
(1001926) Buprenorphine [Presence] in Urine by Screen method
308
1496
2.19
33.06
2.6
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
286
1353
2.24
32.74
6.1
3.8
mmol/l
1.7
1.7
0.08
235
1087
(3021447) Carbon dioxide [Partial pressure] in Venous blood
288
1367
2.24
32.71
6.0
3.8
kpa
6.1
5.8
3.51
281
1321
(3008295) Osmolality of Serum or Plasma
78
174
4.58
32.49
4.5
1.8
mosm/kgh2o
282.7
283.6
0.16
61
136
(3022096) Basophils/100 leukocytes in Blood
1264
9483
1.62
32.42
7.5
5.6
%
0.7
0.7
1.48
1189
8857
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
57
97
5.98
32.13
6.2
4.4
umol/l
163.8
152.1
0.10
33
58
(3013707) Erythrocyte sedimentation rate by Westergren method
1833
15099
1.66
31.84
4.1
3.6
mm/h
9.0
9.6
1.76
1725
14063
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1213
9111
1.60
30.26
4.9
5.1
umol/l
9.7
10.4
1.90
1125
8495
(3006504) Eosinophils/100 leukocytes in Blood
1290
9863
1.59
29.62
7.4
5.5
%
2.6
2.8
1.85
1213
9200
(3019069) Monocytes/100 leukocytes in Blood
1296
9926
1.58
29.49
7.6
5.8
%
8.1
8.0
0.87
1227
9337
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
567
3525
1.77
29.25
1.8
1.6
pmol/l
7771421.4
31186411.6
1.21
489
3027
(3023103) Potassium [Moles/volume] in Serum or Plasma
2338
20781
1.89
28.90
16.9
10.4
mmol/l
3.9
3.9
1.69
2280
20044
(3009466) Valproate [Moles/volume] in Serum or Plasma
91
250
3.73
28.72
6.3
5.2
umol/l
363.4
370.3
0.16
75
214
(3016879) Cocaine [Presence] in Urine
333
1755
2.02
28.65
2.6
2.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2333
20737
1.88
28.63
16.8
10.3
mmol/l
139.3
139.5
3.42
2281
20062
(3018010) Neutrophils/100 leukocytes in Blood
1321
10279
1.55
27.24
7.2
5.3
%
55.2
56.4
3.55
1250
9669
(3002030) Lymphocytes/100 leukocytes in Blood
1335
10415
1.55
27.19
7.4
5.5
%
30.4
29.6
1.67
1264
9761
(3022948) Iron [Moles/volume] in Serum or Plasma
464
2785
1.80
26.74
2.9
2.2
umol/l
13.8
14.2
0.56
425
2560
(3021589) Normoblasts [#/volume] in Blood
1240
9557
1.55
26.40
10.4
7.9
e9/l
0.0
0.0
1.17
1026
7906
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2300
20477
1.80
26.39
6.4
4.6
mu/l
2.6
1.8
0.44
2181
19277
(40758558) Short blood count panel - Blood
725
4937
1.64
26.27
7.1
5.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
239
1147
2.19
26.26
5.0
3.3
kpa
4.6
4.6
0.05
232
1103
(4198724)
69
168
4.19
25.75
2.3
3.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
341
1915
1.89
24.18
2.7
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
342
1929
1.88
23.91
2.6
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
342
1935
1.88
23.67
2.7
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
378
2229
1.81
22.86
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
294
1614
1.92
22.26
3.1
2.9
%
1.7
1.7
0.09
254
1436
(3004789) Transferrin [Mass/volume] in Serum or Plasma
410
2496
1.76
22.21
2.9
2.2
g/l
2.5
2.5
0.50
373
2294
(3000991) Gas panel - Venous blood
238
1216
2.05
22.13
8.4
8.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
116
434
2.75
21.95
1.4
1.4
ug/g
283.0
301.2
0.32
52
219
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
176
804
2.27
21.76
7.5
4.3
mmol/l
24.0
24.1
0.14
161
732
(3023323) Follitropin [Units/volume] in Serum or Plasma
310
1757
1.86
21.24
1.7
1.4
iu/l
13.2
18.8
4.07
254
1479
(3048689) Calprotectin [Mass/mass] in Stool
524
3463
1.63
20.76
2.5
2.5
ug/g
96.3
102.4
0.15
387
2687
(3009508) Creatinine [Moles/volume] in Urine
700
4984
1.54
20.09
3.4
3.3
mmol/l
7.0
8.0
4.82
616
4344
(3027944) Amphetamines [Presence] in Urine
325
1903
1.80
19.99
2.6
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
532
3630
1.58
18.21
2.8
2.5
mosm/kgh2o
517.6
553.3
2.46
443
3095
(3014111) Lactate [Moles/volume] in Serum or Plasma
229
1238
1.93
18.07
6.4
6.7
mmol/l
1.2
1.3
1.73
218
1175
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
289
1700
1.78
17.42
2.4
2.3
u/l
31.8
66.1
0.63
257
1426
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2123
19124
1.50
16.52
4.1
3.3
mmol/l
5.6
5.6
0.04
1984
17770
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2435
22650
1.72
16.36
10.7
8.0
u/l
24.1
24.3
0.34
2366
21891
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
78
277
2.87
16.33
1.9
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
573
4065
1.52
16.25
4.9
3.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
357
2269
1.66
16.21
3.1
2.3
%
21.8
23.5
1.60
311
1945
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
395
2580
1.62
16.08
1.9
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
697
5171
1.47
15.79
3.2
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
758
5715
1.45
15.78
3.7
2.8
ng/l
42.2
36.5
0.21
388
2810
(3030467) Casts [#/volume] in Urine by Automated count
694
5146
1.47
15.76
3.3
2.8
e6/l
0.3
0.3
0.45
512
3772
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1704
14818
1.40
15.37
3.7
2.7
u/l
31.0
35.3
3.01
1611
14108
(3004119) Hemoglobin [Mass/volume] in Venous blood
160
810
2.04
15.23
5.2
2.9
g/l
129.2
129.9
0.15
155
793
(3009343) pH of Capillary blood
184
988
1.92
14.80
3.9
3.6
ph
7.4
7.4
0.24
29
128
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
268
1617
1.73
14.73
2.5
3.3
pmol/l
4.2
4.6
7.83
232
1450
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
185
999
1.91
14.63
4.0
3.6
kpa
5.3
5.1
2.41
169
947
(44816559) Phosphatidylethanol [Mass/volume] in Blood
113
507
2.28
14.62
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
195
1073
1.88
14.56
4.3
3.8
ng/l
91.8
73.6
1.41
173
973
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
33
73
4.56
13.99
1.7
2.0
nmol/l
0.1
0.2
1.88
27
62
(3023520) Reticulocytes [#/volume] in Blood
200
1124
1.84
13.98
3.4
2.7
e9/l
69.7
71.2
0.20
136
840
(3018095) Leukocytes [#/volume] in Urine
910
7224
1.39
13.77
4.0
3.3
e6/l
68.0
98.7
0.98
612
4650
(3002582) Erythrocytes [#/volume] in Urine
741
5681
1.42
13.74
3.4
2.9
e6/l
174.3
80.7
0.37
562
4231
(3003327) Ova and parasites identified in Stool by Light microscopy
169
906
1.92
13.67
2.0
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
604
4472
1.45
13.53
4.0
3.6
%
94.0
94.7
0.32
586
4338
(3000850) Epithelial cells [#/volume] in Urine
539
3907
1.47
13.47
2.7
2.4
e6/l
8.8
8.6
0.10
469
3412
(3052851) Hemolysis interference index of Serum or Plasma
107
489
2.24
13.28
3.1
3.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
90
382
2.40
13.24
3.4
2.4
mmol/l
24.4
24.2
0.21
78
346
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
177
974
1.87
13.22
2.5
2.1
ug/l
7.6
6.7
0.08
157
859
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2099
19124
1.43
13.09
12.6
8.6
ml/min/173m2
96.6
94.1
4.57
1674
15146
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
175
963
1.87
13.07
4.0
3.6
mmol/l
2.0
1.3
2.03
130
680
(3037522) Nuclear Ab [Titer] in Serum
439
3082
1.51
12.80
1.3
1.4
titre
343.3
554.1
3.56
84
612
(3042936) Bacteria identified in Isolate by Culture
365
2474
1.55
12.52
1.9
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
813
6422
1.38
12.40
3.1
2.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
208
1241
1.73
11.88
9.0
7.3
mmol/l
7.9
7.9
0.04
203
1183
(40768797) Stomach Pathology biopsy report
344
2334
1.54
11.71
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
289
1885
1.60
11.69
8.4
5.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
261
1668
1.62
11.48
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
264
1699
1.61
11.28
1.7
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
194
1159
1.72
11.03
1.8
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
168
2.95
11.03
1.7
1.6
promille
0.7
1.3
2.76
34
133
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
209
1282
1.68
10.79
4.0
3.1
mmol/l
1.2
1.2
0.26
182
1096
(40760892) CBC W Ordered Manual Differential panel - Blood
690
5414
1.37
10.70
5.1
3.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
94
446
2.15
10.69
3.5
3.5
kpa
8.8
9.0
0.51
85
421
(3003396) Base excess in Arterial blood by calculation
225
1411
1.65
10.67
5.1
8.2
mmol/l
1.7
0.8
1.55
180
1055
(1616796) Gas panel - Central venous blood
81
363
2.27
10.60
4.0
3.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
227
1436
1.63
10.40
1.2
1.2
titre
90.7
230.0
—
7
37
(3042517) Benzodiazepines panel - Urine
20
37
5.44
10.39
3.0
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
305
2070
1.53
10.34
2.1
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
626
4864
1.37
10.26
4.3
3.3
kg/l
1.0
1.0
0.74
64
738
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
185
1118
1.70
10.10
1.1
1.1
u/ml
0.8
6.7
—
6
12
(3024928) Oxygen saturation in Venous blood
70
303
2.34
9.94
7.0
2.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
221
1421
1.60
9.48
5.2
8.1
kpa
12.6
13.2
0.68
213
1358
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
221
1421
1.60
9.48
5.2
8.2
kpa
5.1
5.0
0.54
213
1356
(3031040) Bacteria [#/volume] in Urine by Automated count
1692
15216
1.30
9.37
5.2
3.9
e6/l
793.5
2018.7
0.86
23
182
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
107
561
1.94
9.32
1.7
1.4
u/l
9.1
17.1
5.02
94
486
(3021901) Oxygen saturation in Capillary blood
62
262
2.40
9.31
3.4
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
633
4998
1.35
9.23
4.1
3.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
407
2995
1.42
9.11
2.8
2.2
u/l
7405.3
6426.0
0.20
146
1219
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
140
808
1.77
9.02
1.8
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
323
2286
1.47
8.90
1.3
1.2
iu/ml
107.1
153.0
1.57
93
879
(3037467) Urinalysis macro (dipstick) panel - Urine
1725
15605
1.29
8.84
4.8
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
591
4653
1.34
8.72
2.1
1.8
mg/l
0.9
1.0
0.54
398
3369
(3010421) pH of Blood
83
408
2.07
8.68
4.6
3.6
ph
7.4
7.4
0.54
69
343
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
10
10
10.03
8.64
1.4
1.4
nmol/l
378.2
637.0
—
10
10
(3015171) Extractable nuclear Ab [Units/volume] in Serum
155
934
1.70
8.58
1.2
1.3
u/ml
3.6
1.0
—
9
68
(3002385) Erythrocyte distribution width [Ratio]
2099
19521
1.33
8.57
18.9
12.2
%
13.3
13.4
2.73
2066
19107
(40761535) Cells panel - Urine sediment
211
1378
1.58
8.48
4.5
3.1
—
—
—
0
0
(3013512) EKG study
544
4249
1.35
8.44
3.8
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
377
2773
1.42
8.43
3.5
3.1
ng/l
198.2
462.2
1.16
201
1599
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
385
2848
1.41
8.33
2.9
2.6
e6/l
3.8
4.2
0.23
187
1471
(3023183) Ammonium ion [Moles/volume] in Plasma
64
291
2.23
8.17
2.8
3.3
umol/l
29.8
34.3
1.07
54
250
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
401
2998
1.40
8.15
2.8
2.4
e6/l
1.2
1.3
0.12
203
1617
(3003181) Sodium [Moles/volume] in Urine
50
204
2.48
8.14
2.2
1.5
mmol/l
58.5
66.3
0.37
31
178
(3012501) Base excess in Blood by calculation
72
346
2.11
8.01
4.7
3.6
mmol/l
2.8
2.3
0.56
47
193
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
111
620
1.82
8.00
1.6
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
253
1742
1.50
7.99
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
111
623
1.81
7.88
2.0
2.1
g/l
1.3
1.4
0.32
99
548
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2334
22129
1.39
7.87
15.1
10.3
mg/l
20.2
20.3
0.08
1700
17003
(3035350) Ketones [Presence] in Urine by Test strip
1272
11187
1.26
7.79
4.0
3.2
estimate
0.0
0.0
0.80
266
2334
(40767503) Oxygen content in Capillary blood by calculation
65
304
2.17
7.76
3.4
2.2
%
17.4
16.8
0.62
36
157
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
284
2030
1.44
7.42
2.2
2.8
umol/l
5.1
7.0
2.44
231
1705
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
14
26
5.40
7.24
1.1
1.2
ng/l
33.9
40.1
—
8
15
(3020891) Body temperature
91
496
1.86
7.13
5.5
4.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
119
704
1.72
7.09
4.1
4.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
109
629
1.76
7.09
5.9
10.5
mmol/l
24.7
24.0
0.96
100
594
(3021601) Nitrite [Presence] in Urine by Test strip
1264
11201
1.24
6.93
5.3
4.4
estimate
0.0
0.0
0.50
269
2397
(3009261) Glucose [Presence] in Urine by Test strip
1271
11272
1.24
6.91
4.1
3.2
estimate
0.0
0.0
0.03
264
2335
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
20
6.02
6.90
4.9
8.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1528
1.49
6.85
17.6
17.2
inr
1.3
1.2
0.60
34
237
(3017446) Testosterone [Moles/volume] in Serum or Plasma
174
1144
1.56
6.83
1.7
1.9
nmol/l
8.9
9.2
0.17
145
1006
(3007853) Bacteria identified in Skin by Aerobe culture
319
2364
1.40
6.80
2.0
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
111
653
1.73
6.77
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
723
6029
1.27
6.74
6.1
6.5
inr
1.1
1.1
0.61
257
2034
(3017143) Hepatitis C virus Ab [Presence] in Serum
503
4013
1.31
6.60
1.8
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
26
84
3.11
6.58
1.2
1.6
nmol/l
111.8
137.2
2.55
26
84
(3019060) Gas panel - Arterial blood
127
785
1.65
6.46
3.7
5.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
109
647
1.71
6.45
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
110
657
1.70
6.37
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
263
1908
1.42
6.34
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
55
262
2.12
6.33
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
235
1675
1.44
6.24
3.4
2.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
289
2145
1.39
6.10
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1817
16858
1.23
6.04
4.8
4.2
mmol/mol
38.0
37.6
0.89
1681
15872
(3023511) Choriogonadotropin [Units/volume] in Urine
225
1603
1.44
6.00
1.4
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
16
6.27
5.95
1.4
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
408
3212
1.32
5.86
3.0
2.9
ng/l
2221.1
1107.5
1.06
327
2619
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
130
832
1.59
5.77
1.1
1.1
u/ml
4.6
5.1
0.11
20
126
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
85
486
1.77
5.77
2.4
2.3
ug/l
233.7
342.4
0.43
68
442
(3018677) aPTT in Platelet poor plasma by Coagulation assay
322
2454
1.35
5.77
2.8
2.2
s
29.4
29.4
0.00
308
2375
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
72
396
1.84
5.56
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
158
1066
1.51
5.56
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
322
2470
1.34
5.52
1.6
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
713
6072
1.24
5.34
4.6
3.4
estimate
0.0
0.0
1.94
269
2342
(3017181) Myelocytes/100 leukocytes in Blood
214
1551
1.41
5.21
4.0
4.2
%
1.1
0.9
0.31
61
365
(3002179) Metamyelocytes/100 leukocytes in Blood
199
1428
1.42
5.13
3.8
4.0
%
0.8
0.5
0.40
46
276
(3019225) pH of Specimen
209
1518
1.41
5.03
6.6
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
205
1487
1.41
4.98
4.0
4.3
%
0.1
0.1
0.33
59
335
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
443
3599
1.28
4.98
1.3
1.3
u/ml
10.8
9.6
0.07
170
1454
(3017315) Amylase [Enzymatic activity/volume] in Urine
26
99
2.64
4.98
1.7
1.3
u/l
218.0
346.9
0.56
26
89
(3025159) Blasts/100 leukocytes in Blood
198
1429
1.42
4.95
4.0
4.3
%
0.2
0.6
0.57
51
290
(3017509) Phencyclidine [Presence] in Urine
15
42
3.58
4.76
2.8
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
182
2488
0.71
4.68
1.5
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
131
884
1.51
4.65
1.7
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
30
127
2.38
4.64
2.6
2.6
%
54.7
53.5
0.10
17
92
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
839
7353
1.20
4.60
2.8
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
132
895
1.50
4.59
2.2
3.1
ng/l
196.2
165.3
0.19
109
800
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
768
6685
1.21
4.52
2.6
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
103
665
1.57
4.48
5.0
11.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
209
1554
1.37
4.41
2.4
2.5
g/l
9.9
10.5
1.59
180
1431
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
35
3.73
4.36
1.2
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
150
1055
1.45
4.35
1.4
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
54
295
1.85
4.34
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
194
1431
1.38
4.30
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
573
4872
1.22
4.25
2.5
2.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
19
67
2.85
4.22
5.6
4.3
mg/l
66.6
71.7
0.11
13
51
(3018405) Lactate [Moles/volume] in Arterial blood
74
449
1.67
4.16
4.2
3.9
mmol/l
1.5
1.4
0.55
74
443
(3013139) Helicobacter pylori Ag [Presence] in Stool
187
1380
1.38
4.14
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
121
825
1.49
4.13
2.7
2.4
s
20.5
21.1
0.82
97
700
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
52
3.09
4.08
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
459
3831
1.24
4.05
1.3
1.3
iu/ml
25.4
25.1
0.02
134
1135
(3028026) IgM [Mass/volume] in Serum or Plasma
162
1174
1.40
4.00
1.8
1.6
g/l
1.3
1.4
0.65
145
1084
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
72
439
1.66
3.99
1.1
1.1
u/ml
2.8
2.4
0.14
31
235
(3004809) Band form neutrophils/100 leukocytes in Blood
41
211
1.96
3.96
2.9
3.0
%
1.4
1.4
0.00
30
175
(3044290) Cell count panel - Cerebral spinal fluid
74
456
1.64
3.94
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
238
3038
0.76
3.89
1.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
45
242
1.87
3.83
1.3
1.7
—
28.2
—
0
16
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
57
330
1.74
3.82
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
57
330
1.74
3.82
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
73
452
1.63
3.82
3.1
7.1
mmol/l
1.3
1.2
0.59
68
390
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
525
4470
1.22
3.82
1.6
1.6
mmol/l
1.3
1.3
0.80
455
3906
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
82
523
1.58
3.81
5.2
5.0
mg/l
1.3
1.3
0.18
76
488
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
38
194
1.97
3.77
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
38
194
1.97
3.77
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
38
194
1.97
3.77
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
38
195
1.96
3.72
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
38
195
1.96
3.72
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
38
196
1.95
3.67
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2098
20087
1.19
3.62
20.1
12.6
g/l
332.7
332.8
0.05
2084
19904
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
99
667
1.50
3.62
2.4
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
146
1976
0.72
3.57
1.6
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
98
2.36
3.57
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
106
727
1.48
3.56
1.3
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
216
1682
1.31
3.39
3.9
4.0
u/l
231.6
239.7
0.42
201
1592
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
459
3901
1.21
3.38
2.3
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
83
548
1.53
3.36
1.2
1.4
mg/l
431.4
464.7
0.32
78
521
(3007566) Smooth muscle Ab [Titer] in Serum
79
517
1.54
3.33
1.2
1.4
titre
81.4
89.0
—
7
52
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
180
1372
1.33
3.29
1.2
1.3
au/ml
19.9
33.6
—
5
51
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
51
300
1.71
3.28
4.1
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
103
716
1.46
3.25
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
105
734
1.45
3.23
2.4
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
286
3483
0.80
3.19
2.1
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
191
1478
1.31
3.16
2.3
2.3
au/ml
17.0
18.4
—
9
108
(40761511) CBC panel - Blood by Automated count
2420
23561
1.24
3.15
14.9
9.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
31
158
1.97
3.14
1.1
1.4
mmol/l
1.9
1.8
0.49
31
149
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
105
739
1.44
3.12
2.5
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
41
230
1.79
3.12
1.2
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
9
20
4.51
3.11
1.1
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
74
486
1.54
3.09
1.2
1.5
e6/l
3.7
23.8
3.00
57
374
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
74
486
1.54
3.09
1.3
1.5
e6/l
57.9
8557.2
0.59
64
394
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
50
2.81
3.08
1.3
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
35
188
1.87
3.05
3.8
5.4
mmol/l
6.8
6.5
0.17
28
148
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
361
4269
0.82
3.04
1.5
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
75
497
1.52
3.02
1.2
1.3
mmol/l
3.7
3.5
0.78
66
466
(3011897) Casein IgE Ab [Units/volume] in Serum
17
69
2.47
2.95
1.1
1.1
u/ml
79.2
10.1
—
5
16
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
69
453
1.54
2.91
2.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
1590
0.73
2.85
2.5
2.7
ug/l
0.7
0.8
0.35
82
949
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
34
186
1.84
2.82
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
34
187
1.83
2.78
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1008
9255
1.14
2.77
2.5
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1936
18555
1.15
2.74
3.3
3.0
mmol/l
1.1
1.2
5.20
1791
17508
(3045683) HLA typing for celiac disease panel - Blood or Tissue
35
196
1.80
2.71
1.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
6
10
6.01
2.69
2.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
102
736
1.40
2.69
1.5
2.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
39
647
0.60
2.68
1.4
1.7
mmol/l
6.4
7.4
2.45
25
388
(3006184) Hemoglobin [Mass/volume] in Capillary blood
59
383
1.55
2.64
2.8
2.2
g/l
133.2
131.1
0.30
50
297
(3034770) Mitochondria Ab [Titer] in Serum
76
521
1.47
2.64
1.2
1.3
—
1043.2
—
0
19
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
493
0.54
2.63
1.3
1.6
mmol/l
6.2
6.7
0.47
20
346
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
166
1295
1.30
2.63
2.7
2.3
ml/min/173m2
75.9
77.4
0.16
61
494
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
376
1.55
2.61
3.7
5.7
iu/ml
522.0
496.5
—
5
41
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
41
244
1.69
2.59
1.4
1.5
—
—
—
0
0
(4034850)
82
573
1.44
2.59
10.5
7.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
50
314
1.60
2.58
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
36
207
1.75
2.57
1.3
1.5
pmol/l
526.8
398.9
1.03
30
162
(3000093) Morphology [Interpretation] in Blood Narrative
28
149
1.89
2.55
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
956
8787
1.13
2.54
4.2
3.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
56
2.51
2.52
3.2
3.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
428
1.51
2.52
3.1
1.7
g/l
7.2
7.4
0.28
47
338
(3020682) Albumin/Creatinine [Ratio] in Urine
454
3960
1.18
2.50
4.6
4.1
mg/mmol
16.2
11.8
0.75
314
2660
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2024
19502
1.15
2.50
3.7
3.3
mmol/l
4.6
4.7
3.87
1895
18464
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
167
2100
0.78
2.48
1.5
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
138
1778
0.76
2.48
1.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
29
158
1.84
2.47
1.5
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
12
45
2.67
2.45
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
105
775
1.37
2.44
2.5
2.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
367
1.54
2.43
2.6
1.8
g/l
0.1
0.7
2.81
51
335
(3020630) Protein [Mass/volume] in Serum or Plasma
130
995
1.32
2.39
2.2
2.3
g/l
66.6
67.4
0.71
121
922
(3012516) Albumin [Mass/volume] in Urine
435
3796
1.17
2.38
3.9
3.4
mg/l
648.3
338.5
0.55
296
2550
(3034860) Kappa light chains.free [Mass/volume] in Serum
48
305
1.58
2.38
3.4
2.9
mg/l
36.8
67.2
0.80
39
249
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
144
1119
1.30
2.38
1.5
1.6
mg/l
2.3
3.6
2.41
98
726
(1761868) Lipid panel - Serum or Plasma
717
7878
0.88
2.36
2.3
2.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
72
501
1.45
2.35
1.2
1.2
u/ml
23.7
36.6
—
7
42
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
427
1.49
2.35
3.1
1.7
g/l
3.4
3.8
1.62
47
320
(3011648) Oxygen content in Venous blood
23
118
1.96
2.35
2.1
2.1
%
10.8
11.3
0.20
23
118
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
428
1.48
2.32
3.1
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
92
672
1.38
2.30
3.3
2.9
%
158.4
168.1
0.61
83
641
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
269
1.61
2.29
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
27
148
1.83
2.28
4.6
3.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
67
463
1.46
2.28
1.8
1.9
ug/l
2.3
2.1
0.04
62
412
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
98
725
1.36
2.27
2.9
2.6
%
98.6
92.8
1.91
84
659
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
141
1.85
2.27
1.9
2.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
13
4.62
2.27
22.0
5.7
mmol/l
4.6
6.8
—
6
13
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
398
1.49
2.26
3.3
1.7
g/l
9.6
10.6
0.74
50
349
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
407
1.48
2.24
2.7
1.7
g/l
3.1
3.1
0.01
47
330
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2038
19697
1.14
2.22
3.9
3.6
mmol/l
2.6
2.8
12.18
1891
18510
(3016650) Hepatitis A virus Ab [Presence] in Serum
56
377
1.49
2.18
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
41
257
1.60
2.18
1.5
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
305
1.55
2.16
3.4
2.9
mg/l
27.8
30.2
0.20
38
247
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
21
108
1.95
2.15
1.6
1.4
u/l
5.0
6.4
0.97
16
90
(3004775) Volume in Urine collected for unspecified duration
21
108
1.95
2.15
2.1
2.3
ml
544.3
576.4
0.13
16
75
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
19
3.69
2.15
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
30
3.00
2.14
1.2
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
88
2.05
2.11
1.7
2.4
ug/l
1.3
1.2
0.06
18
81
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
37
2.71
2.10
1.6
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
37
2.71
2.10
1.6
2.9
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
79
573
1.39
2.09
1.6
1.6
—
332.6
—
0
19
(3026389) Candida sp identified in Specimen by Organism specific culture
53
357
1.49
2.07
1.2
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
55
0.00
2.06
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
60
415
1.46
2.06
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
878
8116
1.12
2.04
2.0
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
559
5028
1.14
2.03
2.3
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
192
1.67
2.02
1.1
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
12
50
2.41
2.02
1.1
1.0
ng/l
1149.6
680.7
—
5
31
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
12
50
2.41
2.02
1.1
1.0
ng/l
186.6
270.6
—
5
31
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
12
50
2.41
2.02
1.1
1.0
ng/l
26.0
37.6
—
5
29
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
83
2.05
2.00
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2225
21671
1.15
2.00
16.7
10.8
%
39.1
39.7
4.27
1743
17527
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
59
412
1.44
1.94
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
51
346
1.48
1.94
2.8
2.5
ug/min
136.7
109.4
0.10
26
224
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
149
1.75
1.94
1.9
2.0
%
11.3
12.3
0.25
16
85
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
78
573
1.37
1.93
1.2
1.2
u/ml
16.5
11.5
—
6
91
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
113
1.86
1.91
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
84
629
1.35
1.86
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
107
1.87
1.86
4.5
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
814
8767
0.90
1.85
1.8
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
159
1.70
1.85
2.1
3.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
229
1.58
1.84
3.1
3.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
252
2931
0.84
1.80
1.5
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
23
3.05
1.79
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
29
176
1.65
1.79
1.3
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2551
25153
1.23
1.78
24.2
15.1
e9/l
258.3
262.3
2.74
2503
24539
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
141
1729
0.80
1.75
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
73
541
1.36
1.74
1.9
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
93
715
1.31
1.74
4.7
2.9
g/l
3.8
3.5
0.73
82
678
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
114
901
1.28
1.73
1.5
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
233
1.55
1.73
1.4
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
178
1.64
1.72
1.1
1.1
iu/ml
8.5
7.4
—
7
46
(3024980) IgG subclass 4 [Mass/volume] in Serum
47
324
1.46
1.69
1.1
1.7
g/l
0.5
0.7
1.56
35
241
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
66
484
1.37
1.69
1.8
2.0
mg/l
10.5
9.9
0.28
59
453
(3011412) CD3 cells [#/volume] in Blood
31
195
1.60
1.68
2.0
2.3
e9/l
1.4
1.2
0.80
22
109
(3026361) Erythrocytes [#/volume] in Blood
2552
25179
1.22
1.67
24.2
15.1
e12/l
4.4
4.5
29.38
2498
24534
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
69
511
1.36
1.66
1.3
1.4
u/ml
90.4
108.9
0.74
15
89
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
19
3.16
1.66
1.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
6
19
3.16
1.66
13.0
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
253
2183
1.17
1.64
4.2
3.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
24
142
1.70
1.64
2.3
1.3
umol/l
58.8
65.5
—
5
15
(3024731) MCV [Entitic volume]
2551
25173
1.21
1.63
24.1
15.0
fl
90.5
89.7
17.85
2526
24846
(3051651) Icteric interference index of Serum or Plasma
19
105
1.81
1.62
5.6
4.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
2551
25174
1.21
1.62
24.1
15.0
pg
30.2
29.9
11.24
2526
24845
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1996
19389
1.11
1.62
3.6
3.3
mmol/l
1.6
1.5
14.19
1855
18301
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
120
1.75
1.62
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
54
386
1.41
1.61
2.1
2.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
51
361
1.42
1.61
1.1
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
27
166
1.63
1.61
1.8
2.2
%
50.6
43.8
—
5
23
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
56
2.15
1.61
1.2
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
28
174
1.61
1.60
1.3
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2552
25188
1.21
1.60
24.3
15.1
e9/l
6.4
6.9
20.03
2500
24526
(3028433) Virus identified in Specimen by Culture
13
63
2.07
1.59
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
101
796
1.28
1.59
1.7
1.9
u/l
39.9
38.4
0.28
91
735
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
77
1.95
1.59
1.1
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
184
2166
0.84
1.54
3.6
3.8
%
21.3
21.5
0.06
76
942
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
78
1.93
1.54
1.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
15
78
1.93
1.54
1.0
1.1
%
92.5
96.0
0.16
15
78
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
78
1.93
1.54
1.1
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
726
6735
1.11
1.54
2.4
2.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
27
2.60
1.51
1.3
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
57
417
1.37
1.51
1.4
1.2
u/ml
3.0
4.5
0.93
24
184
(3034274) Bile acid [Moles/volume] in Serum --fasting
114
920
1.25
1.49
2.1
2.5
umol/l
3.5
4.7
3.74
79
684
(3000963) Hemoglobin [Mass/volume] in Blood
2551
25192
1.20
1.49
24.3
15.2
g/l
131.5
133.8
17.60
2528
24861
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
71
539
1.33
1.49
1.4
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
34
226
1.51
1.48
1.3
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
92
1154
0.79
1.44
1.8
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
84
657
1.29
1.43
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
66
1.97
1.43
2.1
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
164
1.59
1.43
1.4
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
57
422
1.36
1.42
1.2
1.2
—
10.8
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
11
211
0.52
1.38
1.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
214
1.50
1.38
1.4
1.2
—
—
—
0
0
(4062490)
32
214
1.50
1.38
1.1
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
167
1.56
1.34
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
14
75
1.87
1.34
1.4
1.2
u/l
16.5
26.7
0.41
14
69
(3020356) Listeria sp identified in Specimen by Organism specific culture
9
42
2.15
1.33
1.2
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
21
128
1.64
1.33
1.4
1.2
—
—
—
0
0
(4306422)
53
393
1.35
1.32
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
31
209
1.49
1.30
1.1
1.4
g/l
6.4
6.4
0.04
21
143
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
209
1.49
1.30
1.1
1.4
g/l
0.6
0.4
0.44
22
140
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
209
1.49
1.30
1.1
1.4
g/l
3.0
2.8
0.26
22
141
(3005082) Progesterone [Moles/volume] in Serum or Plasma
55
412
1.34
1.29
1.4
1.4
nmol/l
35.9
32.2
0.32
49
374
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
51
378
1.36
1.28
1.1
1.1
%
115.1
116.5
0.13
45
341
(3051339) Copper [Moles/volume] in Blood
5
18
2.78
1.28
1.4
1.2
umol/l
18.7
17.4
—
5
18
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
63
814
0.77
1.28
1.2
1.1
u/ml
1.7
1.9
0.11
31
359
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
23
146
1.58
1.25
1.1
1.3
—
250.0
—
0
6
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
48
354
1.36
1.25
2.9
3.9
u/ml
0.3
0.4
0.15
23
191
(3005011) Chlamydia sp Ab [Titer] in Serum
8
36
2.22
1.24
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
50
372
1.35
1.24
1.9
2.7
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
15
85
1.77
1.22
47.4
33.8
ug/l
7.0
7.1
0.03
15
77
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
14
78
1.80
1.21
1.4
1.2
u/l
67.7
86.3
0.44
14
72
(3017732) Neutrophils [#/volume] in Blood
173
1492
1.17
1.19
3.3
2.1
e9/l
3.8
4.2
0.74
131
1249
(3023410) Appearance of Cerebral spinal fluid
34
239
1.43
1.18
1.4
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
50
2.00
1.16
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
33
0.00
1.16
0.0
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
110
1.64
1.15
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
118
1.61
1.14
1.4
1.6
%
35.4
34.9
0.01
11
77
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
191
1.47
1.13
1.8
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
388
1.32
1.11
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
143
1.54
1.11
1.2
1.2
u/l
67.2
55.6
0.23
16
102
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
15
88
1.71
1.11
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
37
268
1.39
1.10
1.5
1.7
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
21
2.38
1.09
2.6
6.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
129
1.55
1.05
2.4
3.4
mg/l
22.4
30.5
0.33
11
97
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
797
7546
1.08
1.04
2.0
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
38
280
1.36
1.03
1.0
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
22
2.27
1.03
1.6
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
138
1.53
1.02
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
408
4418
0.91
1.02
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
99
1.62
0.99
2.3
2.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
49
1.84
0.98
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
61
1.81
0.98
3.9
2.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
23
2.17
0.98
2.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
23
2.17
0.98
2.6
6.0
mg/l
27.4
20.3
—
5
23
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
181
1.44
0.98
1.2
1.2
u/ml
1.0
0.7
—
6
58
(3047007) Chlamydophila sp Ab [Presence] in Serum
51
397
1.29
0.97
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
46
353
1.31
0.97
1.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
59
737
0.80
0.97
1.1
1.1
u/ml
11.0
7.1
0.60
36
422
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
205
1826
1.13
0.94
1.4
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
11
185
0.59
0.94
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
153
1338
1.15
0.93
1.3
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
52
1.73
0.92
7.6
4.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
154
1751
0.87
0.91
1.6
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
28
2.14
0.91
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
701
6639
1.07
0.91
3.4
2.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
86
1.63
0.90
1.4
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
94
1.60
0.90
1.3
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
143
1.47
0.89
2.3
2.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
168
1.43
0.89
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
57
705
0.80
0.88
1.1
1.1
u/ml
3.7
2.7
0.17
16
186
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
95
1.58
0.87
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
73
603
1.22
0.87
1.3
1.3
u/ml
220.0
240.4
0.34
50
372
(3034891) Synovial lining cells/100 cells in Synovial fluid
11
64
1.72
0.86
1.5
1.5
%
3.4
5.6
—
5
19
(3047189) Immunofixation for 24 hour Urine
8
44
1.82
0.85
1.5
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
72
1.67
0.85
1.8
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
56
690
0.81
0.84
1.1
1.1
u/ml
1.0
1.5
0.38
31
307
(4146454)
17
112
1.52
0.84
3.6
2.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
31
1.94
0.84
2.5
2.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
45
1.78
0.84
1.4
2.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
45
353
1.28
0.84
4.3
2.6
nmol/l
0.6
0.9
1.80
38
301
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
162
1.42
0.84
1.6
1.7
—
—
—
0
0
(4094501)
24
331
0.72
0.83
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
73
1.65
0.81
1.6
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
35
267
1.31
0.80
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
32
241
1.33
0.80
2.8
4.3
u/ml
24.6
87.3
—
5
82
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
58
1.73
0.79
1.3
1.3
ug/l
13.1
8.5
—
10
58
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
54
437
1.24
0.79
1.2
1.3
—
6.3
—
0
8
(3035880) pH of Pleural fluid
8
48
1.67
0.78
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
156
1.41
0.78
2.4
3.1
—
—
—
0
0
(4268621)
37
286
1.30
0.78
2.6
2.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
98
1.53
0.78
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
52
420
1.24
0.78
1.4
1.2
u/ml
4.1
3.3
0.14
17
154
(4010399)
137
1208
1.14
0.77
1.3
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
26
191
1.36
0.76
1.0
1.2
ratio
1.0
1.1
—
6
81
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
48
593
0.81
0.76
1.6
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
34
1.77
0.76
3.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
59
1.70
0.75
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
75
1.60
0.74
1.6
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
75
1.60
0.74
1.7
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
75
1.60
0.74
1.6
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
75
1.60
0.74
1.6
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
134
0.60
0.73
1.0
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
108
0.55
0.72
1.7
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
12
76
1.58
0.71
1.0
1.1
iu/ml
—
4.1
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
5
26
1.92
0.70
2.6
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(44806071)
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
14
93
1.51
0.69
1.9
2.1
ml
2545.7
2104.0
0.20
14
87
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
178
1.35
0.68
1.4
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
49
401
1.23
0.68
1.4
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
102
1.47
0.67
1.1
1.1
%
70.0
94.3
—
6
46
(43055514) Macroprolactin [Presence] in Serum or Plasma
21
153
1.37
0.66
1.2
1.3
—
—
—
0
0
(4281824)
12
178
0.67
0.65
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
305
1.25
0.63
2.0
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
246
0.73
0.63
1.0
1.1
u/ml
106.9
3.4
—
7
64
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
47
387
1.22
0.62
1.9
1.6
—
1644.4
—
0
9
(3023430) Cat dander IgE Ab [Units/volume] in Serum
45
545
0.82
0.62
1.1
1.1
u/ml
4.9
7.4
0.59
22
236
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
49
1.63
0.62
1.4
2.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
63
1.59
0.61
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
63
1.59
0.61
1.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
29
226
1.29
0.61
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
46
380
1.21
0.60
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
252
2711
0.92
0.60
4.1
4.2
ug/l
2.4
2.2
0.36
227
2453
(3001556) Androgen free Index in Serum or Plasma
12
80
1.50
0.59
1.3
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
31
245
1.27
0.59
1.1
1.3
—
31.0
—
0
6
(1002224) Polysomnography panel
70
809
0.86
0.58
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
53
1.51
0.58
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
34
273
1.25
0.58
1.4
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
44
364
1.21
0.57
1.2
1.1
iu/ml
108.3
3765.7
0.75
14
106
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
196
0.71
0.57
1.1
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
53
625
0.84
0.57
1.2
1.4
pmol/l
47.5
116.8
1.87
53
607
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
143
1295
1.11
0.57
1.4
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
81
1.48
0.57
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
81
1.48
0.57
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
43
356
1.21
0.56
1.2
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
176
1.31
0.56
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
90
1.45
0.55
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
29
230
1.26
0.55
1.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
99
1.42
0.54
1.4
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
62
1.45
0.53
1.6
2.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
40
1.50
0.51
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
636
6119
1.05
0.51
1.6
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
51
596
0.85
0.51
1.1
1.1
u/ml
7.7
5.3
0.23
23
240
(1761482) Bacteria [#/volume] in Urine by Culture
45
379
1.19
0.51
3.2
3.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
29
233
1.25
0.50
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
1.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
26
207
1.26
0.49
1.1
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
77
680
1.14
0.49
1.6
2.1
iu/l
2.3
4.3
4.07
30
279
(3045414) Leukocytes [Presence] in Urine
107
965
1.11
0.48
1.7
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
75
662
1.14
0.48
3.8
3.4
g/l
0.2
0.4
0.66
32
283
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.5
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
153
0.72
0.45
1.6
1.4
g/l
0.8
0.9
1.60
11
153
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
84
0.59
0.45
1.0
1.1
ng/l
—
304.5
—
0
17
(3008898) HLA-B27 [Presence]
127
1162
1.10
0.45
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
69
1.45
0.44
2.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
7
51
1.37
0.44
2.6
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
127
0.71
0.43
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
31
1.61
0.43
12.8
6.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
31
1.61
0.43
1.0
1.3
%
57.8
56.0
—
5
24
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
32
1.56
0.42
2.4
1.5
mu/l
71.9
104.0
—
5
27
(3037756) Immunofixation for Serum or Plasma
24
194
1.24
0.41
2.4
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.2
—
1.2
—
0
11
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.1
—
0
8
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
183
0.76
0.40
2.1
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
10
138
0.72
0.40
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
177
1.24
0.40
1.5
1.7
%
55.7
54.3
0.05
14
124
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
421
0.85
0.39
3.2
3.2
u/ml
73.3
632.6
0.97
29
356
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
52
591
0.88
0.39
1.6
1.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
35
1.43
0.39
1.8
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
185
1734
1.07
0.38
1.3
1.3
u/ml
206.4
231.9
0.13
175
1602
(4211845)
16
124
1.29
0.38
2.1
2.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
39
335
1.17
0.38
1.7
1.8
e6/l
7570.6
12126.6
0.80
29
245
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
36
1.39
0.38
4.6
4.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
197
1855
1.07
0.36
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
42
480
0.87
0.35
1.1
1.0
u/ml
2.6
0.2
0.42
11
103
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
14
108
1.30
0.35
1.1
1.0
%
80.0
94.9
—
5
50
(3014148) Varicella zoster virus Ab [Titer] in Serum
57
508
1.12
0.35
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
145
0.76
0.34
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
145
0.76
0.34
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
28
236
1.19
0.34
1.1
1.3
—
—
—
0
0
(4024509)
14
178
0.79
0.34
1.6
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
44
1.36
0.34
1.0
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
109
1.29
0.33
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
46
1.30
0.33
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
434
4191
1.04
0.32
2.6
2.3
umol/l
3704.6
4185.7
0.10
384
3741
(3047352) Trisomy 18 risk [Likelihood] in Fetus
191
1807
1.06
0.32
1.5
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
146
1.23
0.32
2.4
2.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
156
1.22
0.30
2.4
2.5
e6/l
886.7
807.3
—
6
65
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1930
19461
0.97
0.30
4.1
3.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
11
84
1.31
0.30
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
278
1.15
0.29
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
401
1.12
0.29
1.6
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
190
1805
1.06
0.29
1.5
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
130
1.23
0.28
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
130
1.23
0.28
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
130
1.23
0.28
1.5
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
133
1411
0.94
0.28
2.7
2.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
18
149
1.21
0.27
1.1
1.2
—
35.0
—
0
9
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
29
252
1.15
0.27
1.2
1.1
mg/l
30.9
36.2
0.35
20
207
(3044242) Glucose [Moles/volume] in Arterial blood
8
65
1.23
0.27
1.3
2.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
193
2022
0.95
0.27
3.4
3.3
%
35.1
32.6
1.99
143
1497
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
122
1.23
0.26
1.1
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
423
1.11
0.26
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
80
740
1.08
0.26
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
113
1.24
0.26
1.4
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
67
1.19
0.26
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
72
1.25
0.25
1.0
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1068
10833
0.98
0.25
4.4
4.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
87
1.26
0.24
1.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
34
381
0.89
0.24
1.7
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
227
1.15
0.23
1.2
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
18
152
1.18
0.23
1.1
1.2
—
57.0
—
0
10
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
17
143
1.19
0.23
1.1
1.2
—
3.7
—
0
7
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
237
1.14
0.23
1.8
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
125
0.80
0.23
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
168
0.83
0.23
1.8
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
92
0.76
0.22
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
79
1.27
0.22
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
238
1.14
0.22
1.8
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
135
0.81
0.22
1.4
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
286
1.12
0.21
1.4
1.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
4.9
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000492) Spirometry study
214
2061
1.04
0.21
1.5
1.3
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
239
1.13
0.21
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
239
1.13
0.21
1.8
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
6
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.0
—
1.9
—
0
6
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
33.8
—
0
8
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
166
0.84
0.20
1.1
1.1
miu/ml
1872.5
1471.3
0.52
14
166
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
123
0.81
0.20
7.0
7.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
240
1.13
0.20
1.8
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
114
0.79
0.20
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
47
432
1.09
0.20
2.7
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
249
0.88
0.19
1.5
1.4
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
6
52
1.15
0.19
1.0
1.0
u/ml
0.0
2.6
—
6
38
(40765089) Chromosome analysis panel - Blood by G-banded
15
175
0.86
0.19
1.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
53
1.13
0.18
1.2
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
143
0.84
0.18
1.3
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
27
242
1.12
0.18
1.1
1.0
mg/l
243.9
204.5
0.37
22
212
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.17
1.9
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.17
1.9
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
233
1.12
0.17
1.3
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
756
7448
1.02
0.17
1.9
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
62
1.13
0.17
2.0
2.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
62
1.13
0.17
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
243
1.11
0.17
1.8
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
113
1179
0.96
0.16
1.8
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
23
256
0.90
0.16
3.0
3.7
u/ml
22.6
24.9
0.11
23
251
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
206
1.12
0.16
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
111
1.17
0.15
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
111
1.17
0.15
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
83
1.20
0.15
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
117
1123
1.04
0.15
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
140
1.14
0.15
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
150
1.13
0.14
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
673
6814
0.98
0.14
1.9
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
100
0.80
0.13
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
111
1152
0.96
0.13
2.8
3.9
ug/l
7.5
23.3
0.94
82
856
(40768793) Breast Pathology biopsy report
46
489
0.94
0.13
1.2
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
110
0.82
0.13
1.4
1.2
—
—
—
0
0
(4027681)
23
209
1.10
0.13
1.4
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
56
530
1.06
0.13
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
82
785
1.05
0.12
1.6
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
142
1.13
0.12
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
40
426
0.94
0.12
3.9
3.0
mg/l
18.0
24.2
1.07
23
262
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
152
1.12
0.12
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
197
0.91
0.10
1.4
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
46
1.09
0.09
1.8
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
418
1.05
0.09
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
213
1.08
0.09
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
155
1.10
0.09
2.9
2.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
97
1.13
0.09
1.1
1.4
pmol/l
61.3
49.8
—
5
38
(3024471) HLA-A [Type]
6
54
1.11
0.09
1.2
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
55
1.09
0.08
1.2
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
57
1.05
0.08
3.0
2.2
mmol/l
1.8
2.8
—
6
52
(3017569) Oxygen content in Arterial blood
6
58
1.03
0.08
1.2
3.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
113
0.88
0.08
1.4
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
175
1.09
0.08
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
64
0.78
0.08
1.8
3.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
65
673
0.96
0.08
1.4
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
117
1.11
0.08
2.6
2.8
%
48.2
45.5
—
5
41
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
67
1.04
0.08
2.1
2.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
18
166
1.08
0.07
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
73
0.82
0.07
1.5
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
73
0.82
0.07
1.5
1.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
74
1.08
0.07
1.3
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
80
0.87
0.07
2.1
2.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
81
0.86
0.07
1.0
1.0
—
—
—
0
0
(4035726)
127
1295
0.98
0.06
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
245
2418
1.01
0.06
1.3
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
37
355
1.04
0.06
1.2
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
26
247
1.05
0.05
1.0
1.1
u/ml
44.2
3.3
0.43
12
85
(44813793)
21
222
0.95
0.05
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
191
0.94
0.04
2.1
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
189
1.06
0.04
2.3
1.8
mg/l
30.6
23.6
—
5
56
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
248
2456
1.01
0.04
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
229
2267
1.01
0.04
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
49
503
0.97
0.04
2.0
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
88
895
0.98
0.04
2.9
2.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
229
2269
1.01
0.03
1.5
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
131
1.07
0.03
1.9
2.1
u/field
6.3
2.2
—
7
70
(44806118)
23
220
1.05
0.03
1.3
1.4
—
—
—
0
0
(44790049)
23
220
1.05
0.03
1.3
1.4
—
—
—
0
0
(44790048)
23
220
1.05
0.03
1.3
1.4
—
—
—
0
0
(44790047)
23
220
1.05
0.03
1.3
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
24
230
1.04
0.03
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
229
2271
1.01
0.03
1.5
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
171
1.05
0.03
1.5
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
156
1546
1.01
0.02
1.4
1.3
miu/ml
234.2
237.0
0.03
70
778
(3020491) Glucose [Moles/volume] in Blood
19
182
1.04
0.02
1.2
1.8
mmol/l
6.4
6.0
0.19
13
146
(3006462) Nitrate [Presence] in Urine
12
113
1.06
0.01
2.4
2.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
20
207
0.97
0.01
3.3
3.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
75
756
0.99
0.00
1.6
1.6
iu/ml
0.0
0.1
1.04
16
136
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
122
0.98
0.00
2.3
2.6
ug/l
20.8
87.6
0.53
12
110
(3035933) Granulocytes/100 leukocytes in Blood
11
106
1.04
0.00
1.2
2.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
171
0.99
0.00
1.1
1.0
u/l
1.4
1.0
—
5
69
(3003740) Influenza virus B Ag [Presence] in Specimen
54
537
1.01
0.00
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
537
1.01
0.00
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
226
2258
1.00
0.00
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
275
0.98
0.00
2.0
2.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
87.8
—
0
5
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
63
0.95
0.00
1.8
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
72
0.97
0.00
1.3
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
24.3
—
0
7
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
78.5
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
10.7
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
58
0.86
0.00
1.2
1.2
u/l
8.6
13.5
—
5
52
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
118.6
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint F5_ANOREX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANOREX | 3.121 [2.52, 3.86] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.315 |
During the follow-up period (1.1.1998 — 31.12.2019), 338 out of 13011 females with F5_ANOREX died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANOREX | 3.078 [2.19, 4.32] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 157 out of 1192 males with F5_ANOREX died.
Mortality risk
Mortality risk for people of age
years, who have F5_ANOREX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.26% | 0.477% |
| 5 | 1.72% | 3.486% |
| 10 | 4.648% | 8.526% |
| 15 | 9.088% | 15.874% |
| 20 | 15.515% | 25.246% |
Relationships between endpoints
↥Index endpoint: F5_ANOREX – Anorexia (incl.atypical)
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data